JPH0480680B2 - - Google Patents
Info
- Publication number
- JPH0480680B2 JPH0480680B2 JP57023584A JP2358482A JPH0480680B2 JP H0480680 B2 JPH0480680 B2 JP H0480680B2 JP 57023584 A JP57023584 A JP 57023584A JP 2358482 A JP2358482 A JP 2358482A JP H0480680 B2 JPH0480680 B2 JP H0480680B2
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- culture
- iaa
- promoter
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 6
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 4
- 108020004511 Recombinant DNA Proteins 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 102000014150 Interferons Human genes 0.000 claims description 2
- 108010050904 Interferons Proteins 0.000 claims description 2
- 230000003698 anagen phase Effects 0.000 claims description 2
- 229940079322 interferon Drugs 0.000 claims description 2
- PLVPPLCLBIEYEA-AATRIKPKSA-N (E)-3-(indol-3-yl)acrylic acid Chemical compound C1=CC=C2C(/C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-AATRIKPKSA-N 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- PLVPPLCLBIEYEA-UHFFFAOYSA-N indoleacrylic acid Natural products C1=CC=C2C(C=CC(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-UHFFFAOYSA-N 0.000 claims 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108090000467 Interferon-beta Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- -1 30mM Chemical compound 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000711975 Vesicular stomatitis virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 101150009573 phoA gene Proteins 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57023584A JPS58141796A (ja) | 1982-02-18 | 1982-02-18 | ペプチドの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57023584A JPS58141796A (ja) | 1982-02-18 | 1982-02-18 | ペプチドの製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58141796A JPS58141796A (ja) | 1983-08-23 |
| JPH0480680B2 true JPH0480680B2 (de) | 1992-12-21 |
Family
ID=12114621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57023584A Granted JPS58141796A (ja) | 1982-02-18 | 1982-02-18 | ペプチドの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58141796A (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746608A (en) * | 1983-08-22 | 1988-05-24 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing peptides |
| JPS619282A (ja) * | 1984-06-22 | 1986-01-16 | Hitachi Ltd | 遺伝子組換え菌の培養方法 |
| JPH07110232B2 (ja) * | 1985-10-14 | 1995-11-29 | 株式会社日立製作所 | 遺伝子組換え大腸菌の遺伝子生産物を採取する方法および装置 |
| JPH0775536B2 (ja) * | 1986-03-26 | 1995-08-16 | 猛 小林 | 遺伝子組み換え菌を用いた酵素生産装置 |
| US6706189B2 (en) | 1998-10-09 | 2004-03-16 | Zenon Environmental Inc. | Cyclic aeration system for submerged membrane modules |
| KR100768841B1 (ko) | 2000-12-04 | 2007-10-19 | 구보다코포레이션 | 다단 침지식 막분리기 및 그것을 사용한 고농축폐수처리시설 |
| EP1358005B1 (de) | 2000-12-04 | 2006-12-27 | Kubota Corporation | Luftverteiler und spülverfahren dafür |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56145221A (en) * | 1980-03-24 | 1981-11-11 | Genentech Inc | Bacteria polypeptide development using tryptophan promotor operator |
| JPS56154499A (en) * | 1980-04-03 | 1981-11-30 | Biogen Nv | Manufacture of dna order,recombination dna molecule and human fibroblast interferon-like polypeptide |
| JPS584798A (ja) * | 1981-07-01 | 1983-01-11 | Toray Ind Inc | 新規プラスミドおよびそれを使用したインタ−フエロンの製造法 |
| JPS58110600A (ja) * | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
-
1982
- 1982-02-18 JP JP57023584A patent/JPS58141796A/ja active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56145221A (en) * | 1980-03-24 | 1981-11-11 | Genentech Inc | Bacteria polypeptide development using tryptophan promotor operator |
| JPS56154499A (en) * | 1980-04-03 | 1981-11-30 | Biogen Nv | Manufacture of dna order,recombination dna molecule and human fibroblast interferon-like polypeptide |
| EP0041313A2 (de) * | 1980-04-03 | 1981-12-09 | Biogen, Inc. | DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von dem menschlichen Fibroblast-Interferon |
| JPS584798A (ja) * | 1981-07-01 | 1983-01-11 | Toray Ind Inc | 新規プラスミドおよびそれを使用したインタ−フエロンの製造法 |
| JPS58110600A (ja) * | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58141796A (ja) | 1983-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Conway et al. | Promoter and nucleotide sequences of the Zymomonas mobilis pyruvate decarboxylase | |
| US4656131A (en) | Method for producing interferons | |
| JP3036775B2 (ja) | ｒ―グルタミルトランスペプチダーゼの製造法 | |
| US4746608A (en) | Process for producing peptides | |
| JPH0480680B2 (de) | ||
| EP0145174B1 (de) | Neue, physiologisch aktive Polypeptide und deren Herstellungsverfahren | |
| EP0129119B1 (de) | Verfahren zur Herstellung von L-Asparaginsäure | |
| JPH05260979A (ja) | Ｄ−リボースの製造法 | |
| CN112266923B (zh) | 一种表达腺苷蛋氨酸合酶的枯草芽孢杆菌及应用 | |
| KR900004942B1 (ko) | 펩티드(peptide)의 제조방법 | |
| EP0076037A2 (de) | Verstärkte Expression von DNS-Sequenzen | |
| JPS6236196A (ja) | アラニンの製造法 | |
| Sode et al. | Continuous production of α-peptide using immobilized recombinant yeast cells: A model for continuous production of foreign peptide by recombinant yeast | |
| JPH06277073A (ja) | 蛋白質のトランスロケーションマシナリーをコードする遺伝子ｄｎａ | |
| JPS61260892A (ja) | Ｌ−フエニルアラニンの製造法 | |
| JP2521945B2 (ja) | β−チロシナ−ゼの製造法及びβ−チロシナ−ゼ生産菌 | |
| JP4485734B2 (ja) | ５置換ヒダントインラセマーゼ、これをコードするｄｎａ、組み換えｄｎａ、形質転換された細胞および光学活性アミノ酸の製造方法 | |
| JP3489604B2 (ja) | ５−アミノレブリン酸合成酵素遺伝子 | |
| JPH11313683A (ja) | 新規キシロシダーゼ遺伝子、ベクター、それを用いた形質転換体及びその利用 | |
| Kim et al. | Optimization of Culture Conditions and Analysis of Plasmid Stability of a Transformant Bacillus subtilis for Cytidine Deaminase Production | |
| JPH06102022B2 (ja) | 組換え体ｄｎａ、その製造法、およびそれを含むバチルス属細菌 | |
| JP3173619B2 (ja) | ピログルタミルアミノペプチダーゼの製造法 | |
| CN115572704A (zh) | 重组微生物及其构建方法和应用 | |
| Nam et al. | Effect of IPTG Induction on Production of ${\beta} $-Galactosidase-PreS2 Fusion Protein in Recombinant Escherichia coli | |
| JPH01153084A (ja) | 新規微生物及びそれを用いるｌ−アミノ酸の製法 |